CYP1A2 and ADORA2A Genotypes and Endurance Performance.
ConditionHealthy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-35
SponsorMasaryk University
About this trial
The aim of this randomized, double-blind, placebo-controlled experiment will be to assess the potential effect of the selected gene polymorphism (CYP1A2, ADORA2A) on performance after caffeine ingestion.
Eligibility criteria
Qualifiers
healthy person
any training status
within age limits
without contraindications to perform the test on a bicycle trainer
Disqualifiers
Pregnancy
Breast feeding
Cardiovascular disease
Hypertension
Trial design
Treatments tested in this trial
- Caffeine 2 mg
- Caffeine 4 mg
- Caffeine 0 mg
Treatment groups
60 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov